Clinical Trial Update: Efficacy and Safety of Novel Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating efficacy and safety of novel topical calcipotriol formulations in mild to moderate psoriasis (psoriasis vulgaris) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• Calcipotriol (calcipotriol)

Snippet

Sponsor: Lipidor AB | Conditions: Psoriasis Vulgaris | Phase 1, Phase 2 | Status: COMPLETED